Wooree Bio Co Stock

Wooree Bio Co Equity

The The Equity of Wooree Bio Co (082850.KQ) as of Aug 26, 2026 is 204.75 B KRW. In the previous year, The Equity was 212.13 B KRW — a change of -3.48% (lower).

Equity

204.75 BKRW

YoY

-3.48%

Last updated:

In 2026, Wooree Bio Co's equity was 204.75 B KRW, a -3.48% increase from the 212.13 B KRW equity in the previous year.

The Wooree Bio Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
88.00 B KRW
Jan 1, 2019
93.36 B KRW
Jan 1, 2020
111.15 B KRW
Jan 1, 2021
154.94 B KRW
Jan 1, 2022
179.01 B KRW
Jan 1, 2023
199.47 B KRW
Jan 1, 2024
212.13 B KRW
Jan 1, 2025
204.75 B KRW
The Wooree Bio Co Equity history
YEAREquityYoY
204.75 BKRW-3.48%
212.13 BKRW+6.35%
199.47 BKRW+11.42%
179.01 BKRW+15.54%
154.94 BKRW+39.40%
111.15 BKRW+19.06%
93.36 BKRW+6.09%
88.00 BKRW-32.29%
129.96 BKRW+0.74%
129.01 BKRW+1.67%
126.89 BKRW-14.02%
147.57 BKRW—
Access this data via the Eulerpool API
Get Free API Key

Wooree Bio Co Stock analysis

What does Wooree Bio Co do? Wooree Bio Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Wooree Bio Co's Equity

Wooree Bio Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Wooree Bio Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Wooree Bio Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Wooree Bio Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Wooree Bio Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Wooree Bio Co stock

The Equity of Wooree Bio Co is 204.75 B KRW in 2026.

The Equity of Wooree Bio Co changed from 212.13 B KRW to 204.75 B KRW, representing a -3.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Wooree Bio Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Wooree Bio Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Wooree Bio Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Wooree Bio Co